Do GLP-1 medicines such as semaglutide cause cancer?
It is inaccurate to say these medicines cause cancer in every user or have no possible risk. Semaglutide products warn about thyroid C-cell tumours observed in rodents; relevance to humans remains uncertain. The exact product information and personal and family history must guide prescribing.
Details
Which history matters?
US semaglutide labels contraindicate use with personal or family medullary thyroid carcinoma or multiple endocrine neoplasia type 2. An ordinary thyroid nodule or hypothyroidism is not automatically the same diagnosis; clarify the condition with your clinician.
A warning does not predict an individual outcome
Studies differ in design and follow-up. One study headline cannot guarantee lifetime safety. Prescribers balance expected diabetes or weight benefits with established risks and updated product information.
Symptoms worth assessing
Report a neck lump, persistent hoarseness or swallowing difficulty. Severe breathing difficulty needs urgent care. Do not independently arrange repeated scans or tests solely because of treatment; assessment determines their need. Avoid injections from an unknown source.
Related reading: Is Ozempic associated with pancreatitis, and what are the warning signs?.